Exchange Traded Concepts, LLC Vista Gen Therapeutics, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
BUY
$0.09 - $4.8 $4,572 - $243,892
50,811 Added 156.73%
83,230 $9,000
Q3 2022

Oct 07, 2022
BUY
$0.14 - $4.8 $459 - $15,758
3,283 Added 11.27%
32,419 $5,000
Q2 2022

Jul 20, 2022
BUY
$0.88 - $1.73 $19,785 - $38,895
22,483 Added 337.94%
29,136 $26,000
Q1 2022

Apr 26, 2022
BUY
$1.14 - $2.09 $7,584 - $13,904
6,653 New
6,653 $8,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $517M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email